Andrew Uzilov
Papers
2
Total Citations
145
H-Index
2
About
Andrew Uzilov is a pioneering researcher at the intersection of functional genomics and personalized oncology, best known for developing innovative, organism-based drug screening platforms that translate directly into life-saving clinical interventions. His primary research areas include rare cancers, precision medicine, and high-throughput therapeutic screening using model organisms. Uzilov’s landmark 2019 study (107 citations) introduced a personalized platform using Drosophila to identify trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer, resulting in a dramatic 11-month partial response. He further advanced this approach in a 2021 study (38 citations) targeting adenoid cystic carcinoma, a rare salivary gland cancer with limited treatment options, demonstrating that fly-based avatars can uncover effective therapies for notoriously difficult-to-treat malignancies. By bridging the gap between bench science and bedside application, Uzilov has established a paradigm for functional precision medicine, offering hope to patients with ultra-rare or genomically complex cancers where conventional targeted therapies fail. His work represents a powerful fusion of evolutionary biology and clinical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2